Curcumin-arteether combination therapy of Plasmodium berghei-infected mice prevents recrudescence through immunomodulation

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Vathsala, Palakkod G ^a   Dende, Chaitanya ^a   Nagaraj, Viswanathan Arun ^a   Bhattacharya, Debapriya ^b   Das, Gobardhan ^b   Rangarajan, Pundi N ^a   Padmanaban, Govindarajan ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEETHER; CURCUMIN; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; TLR2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; IMMUNITY; IMMUNOMODULATION; INNATE IMMUNITY; LIVER; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX MALARIA; RELAPSE; RESERVOIR; SINGLE DRUG DOSE; SPLEEN; SPLENOMEGALY; ANIMAL; DRUG COMBINATION; DRUG EFFECT; IMMUNOLOGY; MALARIA; METABOLISM; MOUSE MUTANT; PATHOGENICITY;

ANIMALIA; MUS; PLASMODIUM BERGHEI;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CURCUMIN; DRUG THERAPY, COMBINATION; IMMUNOMODULATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; MALARIA; MICE; MICE, MUTANT STRAINS; PLASMODIUM BERGHEI; SPLEEN; TOLL-LIKE RECEPTOR 2;

EID: 84856026996     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029442     Document Type: Article

References (39)

1. Yeung S, Pongtavornpinyo W, Hastings IM, Mills AJ, White NJ, (2004) Antimalarial drug resistance artemisinin-based combination therapy and the contribution of modeling to elucidating policy choices. Am J Trop Med Hyg 71: 179-186.
2. White NJ, (1999) Antimalarial drug resistance and combination therapy. Phil Trans R Soc Lond B Biol Sci 354: 737-749.
3. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, et al. (2009) Artemisinin Resistance in Plasmodium falciparum Malaria. N Engl J Med 361: 455-467.
4. Nosten F, White NJ, (2009) Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg 77: 181-192.
5. Kamya MR, Yeka A, Bukirwa H, Lugemma M, Rwakimari JB, et al. (2007) Artemether-lumefantrine versus dihydroartemisinin-piperaqine for treatment of malaria: a randomized trial. PLoS Clin Trials 2: e20.
6. Karema C, Fanello CI, Van Overmeir C, Van Geertruyden JP, van Doren W, et al. (2006) Safety and efficacy of dihydroaretmisinin/piperaquine (Artekin), for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanden children. Trans R Soc Trop Med Hyg 101: 1105-1111.
7. Reddy RC, Vathasala PG, Keshamouni VG, Padmanaban G, Rangarajan PN, (2006) Curcumin for malaria therapy. Biochem Biophys Res Comm 326: 472-474.
8. Nanadakumar DN, Nagaraj VA, Vathsala PG, Rangarajan PN, Padmanaban G, (2006) Curcumin- artemisinin combination therapy for malaria. Antimicrob Agents Chem 50: 1859-1860.
9. Rougemont M, Van Saanen M, Sahli R, Hinrikson HP, Bille J, et al. (2004) Detection of four Plasmodium species from humans by 18S rRNA gene subunit-based and species-specific real time PCR assays. J Clin Microbiol 42: 5636-5643.
10. Martinelli A, Rodrigues LA, Cravo P, (2008) Plasmodium chabaudi: Efficacy of artemisinin+curcumin combination treatment on a clone selected for artemisinin resistance in mice. Exp Parasitol 119: 304-307.
11. Akhtar F, Rizvi MA, Kar SK, (2011) Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelli infected mice. Biotech Adv BA-06408.
12. Landau I, Chabaud AG, Mora-SilveraI E, Coqulin F, Boulard Y, et al. (1999) Survival of rodent malaria merozoites in the lymphatic network: Potential role in chronicity of the infection. Parasite 6: 311-322.
13. Wykes MN, Kay JG, Manderson A, Liu XQ, Brown DL, et al. (2011) Rodent blood-stage Plasmodium survive in dendrtic cells that infect naïve mice. Proc Natl Acad Sci USA 108: 11205-11210.
14. Song Y, Sonawane ND, Qian L, Pedemonte N, Galietta LJV, et al. (2004) Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models. J Biol Chem 279: 40629-40633.
15. May LA, Tourkina E, Hoffman SR, Dix TA, (2004) Detection and quantitation of curcumin in mouse lung cell cultures by matrix-assisted laser desorption ionization time of flight mass spectrometry. Anal Biochem 337: 62-69.
16. Sarciron ME, Saccharin C, Petavy AF, Peyron F, (2000) Effects of Artesunate, Dihydroartemisinin, and an Artesunate-Dihydroartemisinin combination against Toxoplasma gondii. Am J Trop Med Hyg 62: 73-76.
17. Joe B, Vijayakumar B, Lokesh BR, (2004) Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutri 44: 97-111.
18. Cui L, Miao J, Cui L, (2007) Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum. Inhibition of histone acetylation and generation of reactive oxygen species. Antimicrob Agents Chemother 51: 488-494.
19. Krishnegowda G, Hajjar AM, Zhu J, Douglass EJ, Uematsu S, et al. (2005) Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem 280: 8606-8616.
20. Parroche P, Lauw FN, Goutagny N, Latz E, Monks BG, et al. (2007) Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci USA 104: 1919-1924.
21. Franklin BS, Parroche P, Ataíde MA, Lauw F, Ropert C, et al. (2009) Malaria primes the innate immune response due to interferon-γ induced enhancement of toll-like receptor expression and function. Proc Natl Acad Sci USA 106: 5789-5794.
22. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, et al. (1989) Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320: 1586-1591.
23. Awandare GA, Goka B, Boeuf P, Tetteh JK, Kurtzhals JA, et al. (2006) Increased levels of inflammatory mediators in children with severe Plasmodium falciparum malaria with respiratory distress. J Infect Dis 194: 1438-1446.
24. Nie CQ, Bernard NJ, Schofield BL, Hansen DS, (2007) CD4+ CD25+ Regulatory T cells suppress CD4+ T-Cell function and inhibit the development of Plasmodium berghei- specific TH1 responses involved in cerebral malaria pathogenesis. Infect Immun 75: 2275-2282.
25. Riley EM, Wahl S, Schofield L, (2006) Regulating immunity to malaria Parasite. Immunol 28: 35-49.
26. Shibui A, Hozumi N, Shiraishi C, Sato Y, Iida H, et al. (2009) CD4+ T cell response in early erythrocytic stage malaria: Plasmodium berghei infection in BALB/c and C57BL/6 mice. Parasitol Res 105: 281-286.
27. Su Z, Stevenson MM, (2002) IL-12 is required for antibody-mediated protective immunity against blood stage Plasmodium chabaudi HS malarial infection in mice. J Immunol 168: 1348-1355.
28. Ma s-h, Aheng LI, Liu Y-J, Guo S-Y, Feng H, et al. (2007) Plasmodium Yoelii: Influence of antimalarial agent on acquision of immunity in BALB/C and DBA/2 mice. Exptl Parasitol 116: 266-272.
29. Saraiva M, O'Garra A, (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170-181.
30. Niikura M, Kamiya S, Nakane A, Kita K, Kobayashi F, (2010) IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites. Int J Parasitol 40: 101-108.
31. Ang KKH, Holmes MJ, Kara UAK, (2001) Immune-mediated parasite clearance in mice infected with Plasmodium berghei treatment with manzamine A. Parasitol Res 87: 715-721.
32. Nunes JK, Starnbach MN, Wirth DF, (2009) Secreted antibody is required for immunity to Plasmodium berghei. Infect Immunity 77: 414-418.
33. Ringman JM, Frautschy SA, Cole GM, Cummings JL, (2005) A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res 2: 131-136.
34. Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, et al. (2004) Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304: 600-602.
35. Jagetia GC, Aggarwal BB, (2007) "Spicing up" the immune system by curcumin. J Clin Immunol 27: 19-35.
36. Wells TN, Burrows JN, Baird JK, (2010) Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol 26: 145-151.
37. Waknine-Grinberg JH, McQuillan JA, Hunt N, Ginsburg H, Golenser J, (2010) Modulation of cerebral malaria by fasudil and other immune-modifying compounds. Exp Parasitol 125: 141-146.
38. Mimche PN, Taramelli D, Vivas L, (2011) The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria. Malaria J 10 (Suppl 1): S10 1-9.
39. Tripathi AK, Khan SI, Walker LA, Tekwani BL, Spectrophotometric determination of de novo hemozoin/beta-hematin formation in an in vitro assay. Anal Biochem 325: 85-91.